Literature DB >> 17569069

Screening for syphilis in pregnancy: which is the proper method?

Viroj Wiwanitkit1.   

Abstract

BACKGROUND: Consequences of syphilis in mother, pregnancy, fetus and child are considerable, but preventable. Serological screening must be offered at the first prenatal visit. Presently, the diagnosis of syphilis is dependent mainly on serological tests. The most widely used screening tests for syphilis are the VDRL and the rapid plasma reagin (RPR) and for confirmation the fluorescent treponemal antibody (FTA) and the treponema pallidum hemagglutination (TPHA) tests.
METHOD: The four alternative nodes for diagnosis of can be a) VDRL + FTA, b) VDRL + TPHA, c) RPR + FTA and d) RPR + TPHA. Here the author reports an evaluation of cost utility of those tests in obstetrical practice. According to this study, it can be shown that the cost per accurate diagnosis for VDRL + TPHA is the least expensive choice and for RPR + FTA is the most expensive choice.
CONCLUSION: Therefore, this alternative is the best method for serological diagnosis of syphilis, based on medical laboratory economics principles.

Entities:  

Mesh:

Year:  2007        PMID: 17569069     DOI: 10.1007/s00404-007-0400-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

1.  A cost-utility analysis of Treponema pallidum haemagglutination (TPHA) testing for syphilis screening of blood donors: is the TPHA test useful for syphilis screening in a blood centre?

Authors:  Viroj Wiwanitkit
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

2.  Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Hum Genet       Date:  2014-04

3.  Is routine antenatal venereal disease research laboratory test still justified? Nigerian experience.

Authors:  Betrand O Nwosu; George U Eleje; Amaka L Obi-Nwosu; Ita F Ahiarakwem; Comfort N Akujobi; Chukwudi C Egwuatu; Chukwudumebi O C Onyiuke
Journal:  Int J Womens Health       Date:  2015-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.